Moloney Securities Asset Management, LLC Chimerix Inc Transaction History

Moloney Securities Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$4.76 - $11.25 $147,560 - $348,750	-31,000 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$2.43 - $5.42 $75,330 - $168,020	31,000 New	31,000 $150,000
Q2 2018 Jul 26, 2018	SELL	$4.43 - $5.14 $106,320 - $123,359	-24,000 Closed	0 $0
Q1 2018 Apr 25, 2018	SELL	$4.65 - $5.9 $6,975 - $8,850	-1,500 Reduced 5.88%	24,000 $125,000
Q3 2017 Oct 18, 2017	BUY	$4.35 - $5.25 $110,924 - $133,875	25,500	25,500 $134,000

37M

52.7K

130K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $78.9M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.